43H-28853-07975
1 vaccination
4 coded responses
5 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 970 / OR
- Registered
- 2021-10-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-10-13
Dose 1 — Pfizer-BioNTech
-
2021-10-20
Registered in v-safe
-
2021-10-22
Health check-in — day 7, dose 1Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-28
Survey response — day 14, dose 1MedDRA: Condition aggravated, Emergency care, Fatigue, Muscle spasms, Neck pain, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Symptoms: Some existing neurological symptoms seem to be worsened. Muscle cramping and fatigue are much worse. Neck pain has also been persistent. · Healthcare visit (other): Er visit was 5 days after vaccinationMedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
-
2021-10-29
Call successfulCompleted over the phone
-
2021-11-10
Survey response — day 28, dose 1MedDRA: Fatigue, Headache, Heavy menstrual bleeding, Myalgia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Muscle pain, headache, fatigue, heavy periodMedDRA releases: 2024-11 · check-in free text available
-
2021-11-10
Report sent to call center — day 28, dose 1Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · no matching call case
-
2021-11-17
Survey response — day 35, dose 1MedDRA: Adverse reaction, Hypersensitivity, Rash — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: I keep getting rashes on my face · Healthcare visit (other): Apt in December to see how to proceed w/ second vax after having these allergies/issuesMedDRA releases: 2024-11 · check-in free text available
-
2021-11-17
Report sent to call center — day 35, dose 1Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-11-18
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-04-15
Survey response — 6 months, dose 1MedDRA: Brain fog, Cognitive disorder, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Significant brain fog, fatigue and what feels like cognitive declineMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-10-13 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 2
1 check-in flagged for a call with no call center case on record
Free text
Release 10 — day 14, dose 1
Symptoms: Some existing neurological symptoms seem to be worsened. Muscle cramping and fatigue are much worse. Neck pain has also been persistent.
Healthcare visit (other): Er visit was 5 days after vaccination
Release 10 — day 28, dose 1
Symptoms: Muscle pain, headache, fatigue, heavy period
Release 10 — day 35, dose 1
Symptoms: I keep getting rashes on my face
Healthcare visit (other): Apt in December to see how to proceed w/ second vax after having these allergies/issues
Release 11 — 6 months, dose 1
Symptoms: Significant brain fog, fatigue and what feels like cognitive decline
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Adverse reaction | · | · | ✓ |
| HCVO | Emergency care | · | · | ✓ |
| HCVO | Hypersensitivity | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Cognitive disorder | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Muscle spasms | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Neck pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rash | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release